Product Types & Technology
Specialized Expertise Across Complex Topical and Liquid Drug Products
Pharmaceutical product types are not interchangeable, and neither are the technologies required to develop, scale, and manufacture them successfully. Semi-solids, non-sterile liquids, and advanced lysosomal formulations each present distinct formulation, analytical, manufacturing, and regulatory challenges that demand extensive and focused expertise.
For over 35 years, CPL has served as a pure-play CDMO for semi-solids and non-sterile liquids, with advanced capabilities in micro encapsulation. We combine formulation science, analytical rigor, skin testing, and GMP manufacturing to support complex drug products from molecule to commercialization.
Non-Sterile Liquids
From challenging suspensions to nasal sprays requiring precise delivery, our 35-member pharmaceutical development team ensures liquid formulations are reproducible, scalable, and GMP-ready.
Learn
More
Semi-Solids
Integrated IVPT and IVRT skin testing, manufacturability assessments, and process development deliver topical products that perform consistently from lab through commercial.
Learn
More
Micro Encapsulation
Liposome-in-semisolid matrix formulations allow CPL to enhance stability, modulate release, and improve delivery, unlocking new possibilities for topicals with challenging delivery profiles.
Learn
More
Industry Challenge
Product Complexity Demands Specialized Technology
CPL’s Solution
Product-Specific Expertise, Unified by One Integrated Model
CPL delivers differentiated product-type expertise through a single, integrated development-to-manufacturing ecosystem. Regardless of dosage form or delivery technology, every program benefits from:
- Product-specific formulation and analytical expertise
- Integrated IVRT/IVPT skin testing
- Early development and scale-up manufacturing
- Seamless tech transfer into GMP manufacturing
- Clinical and commercial production under one roof
Why Clients Choose CPL for Complex Product Types
Focused Expertise, Not Generalist Capabilities
CPL is purpose-built for semi-solids, non-sterile liquids, and advanced topical delivery—not stretched across multiple dosage forms.
Technology That Scales
From suspensions to liposome-in-semisolid systems, CPL selects and designs technologies that scale predictably into commercial GMP manufacturing.
Integrated Skin Testing & Analytics
IVRT, IVPT, and analytical method development are embedded into product design, informing decisions early and strengthening regulatory packages.
Continuity from Molecule to Market
Formulation, testing, process development, manufacturing, packaging, and supply chain all operate within a single organization.
Commitment.
Partnership. Legacy.
Leverage CPL’s 35 years of expertise in non-sterile liquids and semi-solids to ensure your program's success. We’ll support your product from molecule to market, or step in at any stage of its product lifecycle.
